Adrianus J de Langen - JoVE Visualize

Showing results (21-30 of 76) with videos related to

Pageof 8

Sort By:

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019

Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patientsJudi N A van Diessen, Margriet Kwint, Jan-Jakob Sonke, et al.

Molecular Imaging and Biology|July 2, 2013

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancerVirginie Frings, Adrianus J de Langen, Maqsood Yaqub, et al.

Lung Cancer (Amsterdam, Netherlands)|May 22, 2023

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort studyChristi M J Steendam, Sophie M Ernst, Sushil K Badrising, et al.

Clinical and Translational Radiation Oncology|March 4, 2022

Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challengesEvert S M van Aken, Yvette M van der Linden, Johannes V van Thienen, et al.

Diagnostics (Basel, Switzerland)|April 23, 2022

Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer PatientsEveline Annette van de Stadt, Maqsood Yaqub, Robert C Schuit, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016

Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung CancerHilâl Tekatli, Niels Haasbeek, Max Dahele, et al.

European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2008

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomographyAdrianus J de Langen, Bianca Klabbers, Mark Lubberink, et al.

Molecular Imaging and Biology|February 28, 2016

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and DelineationFloris H P van Velden, Gerbrand M Kramer, Virginie Frings, et al.

EJNMMI Research|February 9, 2019

Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patientsGuilherme D Kolinger, David Vállez García, Gerbrand M Kramer, et al.

Cancer Treatment and Research Communications|May 31, 2021

Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectivesJana S Hopstaken, Julianne C de Ruiter, Ronald A M Damhuis, et al.

Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:

Pageof 8

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019

Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patientsJudi N A van Diessen, Margriet Kwint, Jan-Jakob Sonke, et al.

Molecular Imaging and Biology|July 2, 2013

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancerVirginie Frings, Adrianus J de Langen, Maqsood Yaqub, et al.

Lung Cancer (Amsterdam, Netherlands)|May 22, 2023

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort studyChristi M J Steendam, Sophie M Ernst, Sushil K Badrising, et al.

Clinical and Translational Radiation Oncology|March 4, 2022

Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challengesEvert S M van Aken, Yvette M van der Linden, Johannes V van Thienen, et al.

Diagnostics (Basel, Switzerland)|April 23, 2022

Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer PatientsEveline Annette van de Stadt, Maqsood Yaqub, Robert C Schuit, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016

Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung CancerHilâl Tekatli, Niels Haasbeek, Max Dahele, et al.

European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2008

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomographyAdrianus J de Langen, Bianca Klabbers, Mark Lubberink, et al.

Molecular Imaging and Biology|February 28, 2016

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and DelineationFloris H P van Velden, Gerbrand M Kramer, Virginie Frings, et al.

EJNMMI Research|February 9, 2019

Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patientsGuilherme D Kolinger, David Vállez García, Gerbrand M Kramer, et al.

Cancer Treatment and Research Communications|May 31, 2021

Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectivesJana S Hopstaken, Julianne C de Ruiter, Ronald A M Damhuis, et al.

Pageof 8